Misplaced Pages

Duloxetine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 22:38, 13 November 2005 editJoyous! (talk | contribs)Administrators81,044 edits No Gods, No Managers, interestingly, did not contain a barcode, presumably in accordance with their staunch anti-capitalist message.← Previous edit Revision as of 12:53, 23 November 2005 edit undo61.246.12.92 (talk) External linksNext edit →
Line 48: Line 48:
==External links== ==External links==
* *
*
* - medlineplus.org * - medlineplus.org
* *

Revision as of 12:53, 23 November 2005

Duloxetine chemical structure of duloxetine
Duloxetine

IUPAC chemical name
CAS number
 ?
ATC code
 ?
Chemical formula C18H19NOS, HCl
Molecular weight 333.38
Bioavailability ?
Metabolism Hepatic Oxidation
Elimination half-life 8-17 hours
Excretion 70% in urine, 20% in feces
Pregnancy category C (USA)
Legal status Prescription only (USA)
Routes of administration Oral

Duloxetine hydrochloride (brand names: Cymbalta/Yentreve) is a medically used drug that primarily targets major depressive disorders (MDD), pain related to diabetic peripheral neuropathy and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Its behavior contrasts to most other dual-reuptake inhibitors.

Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.

Duloxentine is also approved by the FDA for the treatment of diabetic neuropathy.

When used for the treatment of depression, it is commonly prescribed in doses of either 20 mg, 30 mg, or 60 mg. The long-term side-effects are unknown at this time.

External links

Stub icon

This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it.


Antidepressants (N06A)
Specific reuptake inhibitors and/or receptor modulators
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
Tricyclic and tetracyclic antidepressants
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Monoamine oxidase inhibitors
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Adjunctive therapies
Miscellaneous
Categories: